Previous 10 | Next 10 |
2023-07-16 01:17:15 ET Summary Organon & Co's share price has fallen significantly, with a p/e below the sector average and a 5.4% dividend yield, but its cash flows are barely above its nearly $300 million dividend, potentially limiting dividend growth. The company recently m...
2023-07-05 12:57:34 ET South Korea's Celltrion ( OTC:CONIF ) has launched a high-concentration, citrate-free formulated biosimilar of AbbVie's ( NYSE: ABBV ) Humira in the US. The biosimilar, which is called Yuflyma, was approved by the FDA in May. Yuflyma's list price is $6...
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reaffirmed its commitment to the commercial launch of XACIATO [zah-she-AH-toe] (clindamycin phosphate) vaginal gel, 2% with collaborator Organon (NYSE: OGN),...
Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system ...
2023-07-01 16:00:00 ET Buoyed by booming sales of its diabetes drugs, Eli Lilly ( NYSE: LLY ) was the best performing large pharma or biotech in H1 2023, returning an impressive 28% . Coming in second, Vertex Pharmaceuticals ( VRTX ), helped by continued strong revenue f...
Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system ...
2023-06-29 06:52:00 ET Whether you're saving for retirement, want to set aside money for travel, or just want to give yourself a raise, dividend stocks can help give you some extra income to accomplish those goals. Plus, by investing in quality stocks, you can also potentially profit from t...
2023-06-29 05:02:34 ET For further details see: Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent
Second annual report highlights company’s advancements with a focus on innovation and access to ensure a healthier, more sustainable future for women worldwide. Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Envir...
2023-06-08 12:39:22 ET Summary The article discusses leverage ratios such as debt to assets, debt to equity, debt to EBITDA, and debt to free cash flow, as well as the interest coverage ratio. Using company examples, I explain various definitions, when the individual metrics are b...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 31, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce a new significant gold-silver discovery, called the Navidad vein system, on the Ermitaño Mine concessions in Sonora, Mexico where the Company holds a...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...